Nabiximols (brand name Sativex) is a patented medicine containing CBD and THC in equal proportions. The drug was approved by Health Canada in 2005 for prescription to treat central neuropathic pain in multiple sclerosis, and in 2007 for cancer related pain.[32] In New Zealand, Sativex is "approved for use as an add-on treatment for symptom improvement in people with moderate to severe spasticity due to multiple sclerosis who have not responded adequately to other anti-spasticity medication."[33]
A 2016 study in Molecular and Cellular Biochemistry explored how CBD contributed to the fat browning process. Brown fat is a particular type of fat that works to increase energy expenditure, and it produces heat. This allows brown fat to burn more calories, but adults are mostly composed of white fat. In the study, the following was observed as a result of cannabinoid usage:
×